Physician profile
Michael David Mclaughlin
NPI 1053574376
$4,409.49
in general payments reported to CMS, 2019-2025
16 companies · $1,326 in 2025
The $1,326 reported for 2025 was more than what 85% of Psychiatry providers received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $288 · 2020: $165 · 2021: $424 · 2022: $448 · 2023: $772 · 2024: $986 · 2025: $1,326.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,633 · Education: $452.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,632.77 |
| Education | $451.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $1,826.79 | 2019-2025 | |
| Harmony Biosciences LLC | $876.35 | 2020-2025 | Wakix |
| Zoll Respicardia, INC. | $364.60 | 2023-2025 | Remede System |
| Inspire Medical Systems, INC. | $259.01 | 2023-2025 | Inspire |
| Avadel Cns Pharmaceuticals, LLC | $256.68 | 2023-2025 | Lumryz |
| Axsome Therapeutics, INC. | $253.96 | 2023-2025 | Sunosi |
| Lilly USA, LLC | $140.97 | 2025 | Zepbound, Mounjaro |
| Amgen INC. | $124.70 | 2019 | |
| Eisai INC. | $87.90 | 2020-2021 | |
| Azurity Pharmaceuticals, INC. | $54.15 | 2024 | Horizant |
| 3b Medical, INC. | $47.91 | 2025 | Luna |
| Idorsia Pharmaceuticals US INC | $35.70 | 2023-2024 | Quviviq |
| Itamar Medical INC | $32.09 | 2022 | |
| Vanda Pharmaceuticals INC. | $18.67 | 2019 | |
| Janssen Pharmaceuticals, INC | $17.97 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $12.04 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Mclaughlin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.